Viewing nowCombinationLevotitan Tablets 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.

MFDS item code 201606821 · Approved 2016.11.30 · Insurance code 650204750
Treatment of essential hypertension not controlled with monotherapy
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with Amlodipine or Telmisartan monotherapy.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ○ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’).For patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to individuals with allergies to the active ingredient or components, pregnant or potentially pregnant women, nursing individuals, those with severely impaired liver function, or those with severe cardiac issues. Patients with mild liver function impairment, gastrointestinal diseases, decreased kidney function, elderly individuals, or those with specific heart valve diseases need to use this drug with special caution. Side effects like dizziness or swelling of the hands and feet can commonly occur, and severe side effects may occur rarely, so if any abnormal symptoms arise, immediate medical attention should be sought. Pregnant women should not take this drug, and if pregnancy is confirmed, they should stop taking it immediately and switch to alternative treatments. This drug lowers blood pressure and can cause hypotension; in this case, the patient should be laid down and receive appropriate measures such as fluid replacement if necessary. There is a risk of elevated potassium levels in the blood, so patients with kidney disease or heart failure should have regular blood tests to monitor potassium levels. Interactions may occur if taken with other medications, so all medications being taken should be disclosed to healthcare providers. This drug has not been adequately proven to be safe and effective for children, so its use is not recommended. Elderly patients may respond more sensitively to this drug, so care should be taken during administration, and dose adjustments should be made gradually. In case of overdose, severe hypotension, dizziness, acute renal failure, etc., may occur, so immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a container that blocks light. It is best to store it at a temperature between 1°C and 30°C. Storing it this way preserves the medication's effectiveness and safety.
This is a double tablet that is oval, biconvex, and white to light gray in color.
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.